---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-068439"
form_type: "8-K"
ticker: "OLMA"
cik: "0001750284"
company_name: "Olema Pharmaceuticals, Inc."
filed_at: "2023-12-06T23:59:59+00:00"
generated_at: "2026-06-07T17:15:42.396851+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Olema furnishes investor presentation at SABCS; no specific data disclosed

## Summary
- Investor presentation dated December 6, 2023 made available on company website.
- Presentation exhibited as Exhibit 99.1 but full content not included in filing text.
- No financial results, clinical data updates, or guidance changes referenced in the 8-K.

## SEC filing metadata
- accession: 0000950170-23-068439
- form_type: 8-K
- ticker: OLMA
- cik: 0001750284
- company_name: Olema Pharmaceuticals, Inc.
- filed_at: 2023-12-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750284/000095017023068439/0000950170-23-068439-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750284/000095017023068439/olma-20231206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-068439
- JSON: https://secwatch.observer/filing/0000950170-23-068439.json
- Plain text: https://secwatch.observer/filing/0000950170-23-068439.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.